Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis Soo Jin LeeChihwan David ChaMin Sung Chung Original Article 27 April 2024
Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan Hisanori KawamotoKoichiro TsugawaMamoru Fukuda Original Article Open access 27 April 2024
Perspectives for the clinical application of ctDNA analysis to breast cancer drug therapy Tetsuhiro Yoshinami Special Feature 23 April 2024
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors Pei-Jing YangEing-Mei TsaiTsu-Nai Wang Original Article 23 April 2024
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients Kadri Altundag Letter to the Editor 22 April 2024
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database Yuhang ShangXuelian WangBaoliang Guo Original Article Open access 21 April 2024
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status Sei NaMilim KimSo Yeon Park Original Article Open access 21 April 2024
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study Tetsuhiro YoshinamiShigenori E. NagaiNorikazu Masuda Original Article Open access 20 April 2024
French national survey on breast cancer care: caregiver and patient views Christine Rousset-JablonskiBarbara LortalAlain Toledano Original Article Open access 18 April 2024
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer Huan-ping ZhangRui-yuan JiangXiao-jia Wang Review Article Open access 17 April 2024
The usefulness of artificial intelligence in breast reconstruction: a systematic review Karla C. MaitaFrancisco R. AvilaAntonio Jorge Forte Review Article 15 April 2024
Inter- and intra-observer variability of qualitative visual breast-composition assessment in mammography among Japanese physicians: a first multi-institutional observer performance study in Japan Yoichi KoyamaKazuaki NakashimaTakayoshi Uematsu Original Article 15 April 2024
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study Peter J. K. TokudaTakamasa Mitsuyoshithe Kyoto Radiation Oncology Study Group Original Article Open access 12 April 2024
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases Alexandre De MouraDelphine LoiratAlexandre Acramel Original Article Open access 10 April 2024
Association between quality of life and mortality risk in patients with breast cancer: a systematic review and meta-analysis Katsuyoshi SuzukiShinichiro MorishitaTakuya Fukushima Review Article 09 April 2024
Nipple–areolar complex malposition in breast reconstruction after nipple-sparing mastectomy: a multi-institutional retrospective observational study in Japan Sayuri KatoHiroki Morithe Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society Original Article 08 April 2024
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues Akira WatanabeRyo TsunashimaYasuto Naoi Original Article 08 April 2024
The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap Joep A. F. van RooijEnnie BijkerkStefania M. H. Tuinder Original Article Open access 06 April 2024 Pages: 456 - 466
The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition Michio YoshimuraChikako YamauchiShigehira Saji Special Article Open access 05 April 2024 Pages: 347 - 357
Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy Hiroko NogiAkiko OgiyaThe Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society Original Article Open access 04 April 2024 Pages: 507 - 518
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment Yutaka YamamotoChikako YamauchiShigehira Saji Special Article Open access 03 April 2024 Pages: 340 - 346
Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy Dan LinKathleen M. SturgeonCheryl L. Thompson Original Article 02 April 2024 Pages: 519 - 528
The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer Jin-hui YeJian YuYue-mei Mo Original Article Open access 01 April 2024 Pages: 417 - 425
Prospects for liquid biopsy using microRNA and extracellular vesicles in breast cancer Takahiro OchiyaKazuki HashimotoAkihiko Shimomura Special Feature Open access 30 March 2024
Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010–2020 Ewe Seng Ch’ng Original Article 28 March 2024 Pages: 496 - 506
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer Kazutaka NaruiToshihiko SatakeItaru Endo Original Article 21 March 2024 Pages: 476 - 484
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management Kazuki HashimotoTakahiro OchiyaAkihiko Shimomura Special Feature 21 March 2024
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer Kim VoColton LadburyArya Amini Original Article Open access 20 March 2024 Pages: 485 - 495
Liquid biopsy for breast cancer and other solid tumors: a review of recent advances Hirofumi OhmuraFumiyasu HanamuraEishi Baba Special Feature 16 March 2024
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer Xue Hu Review Article 14 March 2024 Pages: 358 - 370
Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile Danbee KangSeri ParkYeon Hee Park Original Article 12 March 2024 Pages: 467 - 475
Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB Guo LiXinyue LinZhichao Fu Original Article 12 March 2024 Pages: 426 - 439
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer Kumiko KidaAkimitsu YamadaTakashi Ishikawa Original Article 08 March 2024 Pages: 409 - 416
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan Yasue TsuchidaNaoki NiikuraNaoki Hayashi Original Article 07 March 2024 Pages: 401 - 408
Deep learning model to predict Ki-67 expression of breast cancer using digital breast tomosynthesis Ken ObaMaki AdachiHiroko Tsunoda Special Feature 07 March 2024
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al. Reiko FukuiTakahiro WatanabeYasuo Miyoshi Letter to the Editor 04 March 2024 Pages: 536 - 538
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines Masaya HattoriNaoko HonmaYutaka Yamamoto Special Article Open access 04 March 2024 Pages: 335 - 339
SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β Monalisa ParijaSurya PrakashSandip K. Mishra Original Article 29 February 2024 Pages: 440 - 455
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Nalee KimWon Kyung ChoHaeyoung Kim Original Article 18 February 2024 Pages: 391 - 400
Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer Kazuhiko SatoHiromi FuchikamiMasahiro Kato Original Article 15 February 2024 Pages: 382 - 390
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer Sean M. HackingGabrielle WindsorYihong Wang Rapid Communication 13 February 2024 Pages: 529 - 535
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy Mikiko KasaharaSayaka KanematsuMasahiro Watatani Original Article 07 February 2024 Pages: 329 - 334
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry Takayuki IwamotoHiraku KumamaruShigehira Saji Special Article 06 February 2024 Pages: 185 - 194
Advances in the study of autophagy in breast cancer Tang YuLiu RuiHu Ying Review Article Open access 05 February 2024 Pages: 195 - 204
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer Jie-Yin ZhuangZe-Nan HuangMin Dong Original Article 04 February 2024 Pages: 317 - 328
Patient-reported outcomes of mesh in minimally invasive (laparoscopic/robot-assisted) immediate subpectoral prosthesis breast reconstruction: a retrospective study Xin WuYu GuiLi Chen Original Article 02 February 2024 Pages: 243 - 251
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models Hongyan ZhengLihua WuGe Lou Original Article 30 January 2024 Pages: 371 - 381
Endosomal protein expression of γ1-adaptin is associated with tumor growth activity and relapse-free survival in breast cancer Nobuhiro HoshiTakefumi UemuraSatoshi Waguri Original Article Open access 24 January 2024 Pages: 305 - 316
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes Wu DingDengfeng YeChuanjian Tu Original Article 17 January 2024 Pages: 295 - 304
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan Yasuaki SagaraHiraku KumamaruShigehira Saji Special Article 05 January 2024 Pages: 179 - 184
